Phenazopyridine for Confirmation of Ureteral Patency

Summary

In this prospective, randomized trial subjects will be randomized to receive phenazopyridine or no medication prior to pelvic reconstructive procedures that use cystoscopy to confirm ureteral patency intraoperatively.

Timeline

Start

2015-04

Primary completion

2016-01

Completion

2016-01

Outcome

Missed primary endpoint

registry Control vs Phenazopyridine; p = 0.77; t-test, 2 sided NCT02424149 ↗

paper Time to visualize ureteral urine efflux did not differ between study groups PMID 27399998 ↗

Publications

• Propst K, Tunitsky-Bitton E, O'Sullivan DM, Steinberg AC, LaSala C. Phenazopyridine for Evaluation of Ureteral Patency: A Randomized Controlled Trial. Obstet Gynecol. 2016 Aug;128(2):348-355. doi: 10.1097/AOG.0000000000001472.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Phenazopyridine	Small molecule	—	—

Indications

No indication recorded.